New Medicines in Development Database
Today, over 2,000 new medicines are in development. Many of these potential new medicines will fail in clinical trials, but some may represent tomorrow's new treatments. Bringing each new medicine to patients will require, on average, 10-15 years of testing and review.
This database includes medicines currently in clinical trials or at FDA for review. The information contained in this database was derived from Wolters Kluwer Health's Adis R&D Insight and is published with permission under license with Wolters Kluwer Health. PhRMA has not reviewed or verified this information.
Explore our database of new medicines in development and find out what the future may hold.
